Every year, thousands of Americans are diagnosed with glaucoma, a disease that occurs when too much pressure builds up in the fluid inside of the eye. If left untreated, glaucoma can result in partial vision loss and even blindness.
While glaucoma generally cannot be cured, glaucoma can be treated and controlled if it is diagnosed early enough.
Thanks to a new treatment discovered at the University of Michigan’s Kellogg Eye Center, glaucoma patients may not have to worry about some of the risks associated with traditional treatment options.
- The stent, called the XEN Gel Stent, can be used to create a small opening between the inner part of a person’s eye and the outer layer of the eye.
- The placement of the stent allows for fluid to drain from the eye, relieving pressure and reducing the effects of glaucoma.
Approved by the FDA in late 2016, the stent is only about six millimeters long, and is made out of a gelatin material that is comfortable for patients.
Although the stent isn’t ideal for people who are facing severe glaucoma, but it has proven to be effective in mild to moderate glaucoma cases. With early diagnosis and treatment, the stint could prevent the condition from worsening over time.
Ophthalmology Associates of Western New York can test your eyes for glaucoma and offers excellent treatment options if the disease has affected your vision.
From prescription eye drops to glaucoma surgery, which can prevent damage to the optic nerve, we specialize in helping WNY area patients who are suffering from glaucoma.
To learn more, give us a call at 716-632-3545 today.